Antiviral Drug Ingavirin® Included in the Minimum Assortment of Medicinal Preparations for Medical Institutions and Pharmacy Organizations
Since January 1, 2019, Valenta Pharm’s antiviral drug Ingavirin® has been included in the minimum assortment of medicinal preparations necessary for rendering medical assistance (staple drugs).
The minimum assortment of medicinal preparations is developed by the commission of the Ministry of Health of the Russian Federation to ensure that patients have access to the most popular and necessary medicines for providing medical care, which must be present in all medical institutions and pharmacy organizations.
The decision to include Ingavirin® in the minimum assortment of medicinal preparations was made by the commission of the Ministry of Health of the Russian Federation, which includes the heads of key departments of the Ministry of Health, the Ministry of Industry and Trade of the Russian Federation, the Ministry of Finance of the Russian Federation, the Ministry of Labor and Social Protection of the Russian Federation, the Ministry of Regional Development of the Russian Federation, the Federal Service for Surveillance in Healthcare, the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, the Federal Antimonopoly Service, the Federal Medical and Biological Agency, the Federal Agency for Scientific Organizations, other federal executive authorities, federal state educational institutions of higher medical and pharmaceutical education, as well as the federal state medical and pharmaceutical research organizations.
Anastasia Morozova,,Group Product Manager, Cold-Relief Medicines Business Unit states: “As the original, innovative product of Valenta Pharm, Ingavirin® is an expert in treatment and prevention of influenza and ARVI. The efficacy and safety of the drug is confirmed by both the results of clinical studies and years of therapeutic experience. Ingavirin® is a drug that annually helps millions of people cope with some of the most common viral diseases. The inclusion of Ingavirin® in the minimum assortment of medicinal preparations will make the drug available to an even greater number of patients.”
To get acquainted with the Order of the Government of the Russian Federation dated December 10, 2018 No. 2738-r, follow the link: http://government.ru/docs/35024/